Skip to main content

Advertisement

Log in

Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Management of classic lobular neoplasia (cLN) diagnosed on core needle biopsy (CNB) is controversial. Our aim in this study was to review cases of cLN diagnosed on CNB to determine the rate and risk factors of an upgrade to ductal carcinoma in situ (DCIS) or invasive carcinoma on excision. All breast CNBs with a diagnosis of atypical lobular hyperplasia (ALH) or classic lobular carcinoma in situ (cLCIS) from three different institutions within a single health care system between 2013 and 2018 were retrieved. Cases with any additional high-risk lesions in the same CNB or discordant radiological-pathological correlation were excluded. Information about age, personal history of prior or concurrent breast cancer (P/CBC), and radiological and histological findings were recorded. A total of 287 cLN cases underwent surgical excision. Analysis of these 287 cLN cases showed 11 (3.8%) upgrade lesions on excision. Among the 172 ALH cases, there were 3 (1.7%) upgrades, which were all invasive lobular carcinomas (ILCs). On the other hand, 8 of 115 (7%) cLCIS cases revealed upgrade on excision (2 ILC, 5 DCIS. and 1 ILC + DCIS). Statistical analysis revealed that cLN cases with P/CBC, radiological asymmetry, or architectural distortion had a statistically significant higher upgrade rate on excision. Our findings revealed a low upgrade rate (3.8%) on the excision of classic lobular neoplasia diagnosed on breast core needle biopsy. Clinicoradiological surveillance can be appropriate when lobular neoplasia is identified on core biopsy with pathological radiological concordance in patients without a history of breast cancer, with the caveat that radiological asymmetry and architectural distortion are associated with a significant increase in an upgrade on excision.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (2012) WHO classification of tumours of the breast. International Agency for Research on Cancer, Lyon

    Google Scholar 

  2. Rosen P, Hoda S, Dershaw D, Liberman L, Rosen P (2006) Breast pathology. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  3. Jorns J, Sabel M, Pang J (2014) Lobular neoplasia: morphology and management. Arch Pathol Lab Med 138(10):1344–1349

    PubMed  Google Scholar 

  4. Ginter PS, D'Alfonso TM (2017) Current concepts in diagnosis, molecular features, and management of lobular carcinoma in situ of the breast with a discussion of morphologic variants. Arch Pathol Lab Med 141(12):1668–1678

    CAS  PubMed  Google Scholar 

  5. Beute B, Kalisher L, Hutter R (1991) Lobular carcinoma in situ of the breast: clinical, pathologic, and mammographic features. Am J Roentgenol 14(3):248

    Google Scholar 

  6. Georgian-Smith D, Lawton T (2001) Calcifications of lobular carcinoma in situ of the breast. Am J Roentgenol 176(5):1255–1259

    CAS  Google Scholar 

  7. Wazir U, Wazir A, Wells C et al (2016) Pleomorphic lobular carcinoma in situ: current evidence and a systemic review. Oncol Lett 12(6):4863–4868

    PubMed  PubMed Central  Google Scholar 

  8. Shamir ER, Chen YY, Chu T et al (2019) Pleomorphic and florid lobular carcinoma in situ variants of the breast. Am J Surg Pathol 43(3):399–408

    PubMed  Google Scholar 

  9. Foschini MP, Miglio R, Fiore R et al. (2019) Pre-operative management of pleomorphic and florid lobular carcinoma in situ of the breast: report of a large multi-institutional series and review of the literature. Eur J Surg Oncol https://doi.org/10.1016/j.ejso.2019.07.011

    PubMed  Google Scholar 

  10. Nakhlis F, Harrison BT, Giess CS, Lester SC, Hughes KS, Coopey SB, King TA (2019) Evaluating the rate of upgrade to invasive breast cancer and/or ductal carcinoma in situ following a core biopsy diagnosis of non-classic lobular carcinoma in situ. Ann Surg Oncol 26(1):55–61

    PubMed  Google Scholar 

  11. Schmidt H, Arditi B, Wooster M, Weltz C, Margolies L, Bleiweiss I, Port E, Jaffer S (2018) Observation versus excision of lobular neoplasia on core needle biopsy of the breast. Breast Cancer Res Treat 168(3):649–654

    PubMed  Google Scholar 

  12. Susnik B, Day D, Abeln E, Bowman T, Krueger J, Swenson KK, Tsai ML, Bretzke ML, Lillemoe TJ (2016) Surgical outcomes of lobular neoplasia diagnosed in core biopsy: prospective study of 316 cases. Clin Breast Cancer 16(6):507–513

    PubMed  Google Scholar 

  13. Foster M, Helvie M, Gregory N, Rebner M, Nees A, Paramagul C (2004) Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology 231(3):813–819

    PubMed  Google Scholar 

  14. Houssami N, Ciatto S, Bilous M, Vezzosi V, Bianchi S (2007) Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3). Br J Cancer 96(8):1253–1257

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Hwang H, Barke L, Mendelson E, Susnik B (2008) Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol 21(10):1208–1216

    PubMed  Google Scholar 

  16. Ibrahim N, Bessissow A, Lalonde L, Mesurolle B, Trop I, Lisbona A, el-Khoury M (2012) Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia? Am J Roentgenol 198(2):288–291

    Google Scholar 

  17. Karabakhtsian R, Johnson R, Sumkin J, Dabbs D (2007) The clinical significance of lobular neoplasia on breast core biopsy. Am J Surg Pathol 31(5):717–723

    PubMed  Google Scholar 

  18. Brem R, Lechner M, Jackman R, Rapelyea JA, Evans WP, Philpotts LE, Hargreaves J, Wasden S (2008) Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. Am J Roentgenol 190(3):637–641

    Google Scholar 

  19. Nakhlis F, Gilmore L, Gelman R, Bedrosian I, Ludwig K, Hwang ES, Willey S, Hudis C, Iglehart JD, Lawler E, Ryabin NY, Golshan M, Schnitt SJ, King TA (2015) Incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020). Ann Surg Oncol 23(3):722–728

    PubMed  PubMed Central  Google Scholar 

  20. Londero V, Zuiani C, Linda A, Vianello E, Furlan A, Bazzocchi M (2008) Lobular neoplasia: core needle breast biopsy underestimation of malignancy in relation to radiologic and pathologic features. Breast 17(6):623–630

    PubMed  Google Scholar 

  21. Mahoney M, Robinson-Smith T, Shaughnessy E (2006) Lobular Neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. Am J Roentgenol 187(4):949–954

    Google Scholar 

  22. Menon S, Porter G, Evans A, Ellis IO, Elston CW, Hodi Z, Lee AH (2008) The significance of lobular neoplasia on needle core biopsy of the breast. Virchows Arch 452(5):473–479

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Middleton L, Sneige N, Coyne R, Shen Y, Dong W, Dempsey P, Bevers TB (2014) Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting. Cancer Med 3(3):492–499

    PubMed  PubMed Central  Google Scholar 

  24. Mulheron B, Gray R, Pockaj B, Apsey H (2009) Is excisional biopsy indicated for patients with lobular neoplasia diagnosed on percutaneous core needle biopsy of the breast? Am J Surg 198(6):792–797

    PubMed  Google Scholar 

  25. Murray M, Luedtke C, Liberman L, Nehhozina T, Akram M, Brogi E (2012) Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy. Cancer 119(5):1073–1079

    PubMed  Google Scholar 

  26. Nagi C, O'Donnell J, Tismenetsky M, Bleiweiss I, Jaffer S (2008) Lobular neoplasia on core needle biopsy does not require excision. Cancer 112(10):2152–2158

    PubMed  Google Scholar 

  27. Niell B, Specht M, Gerade B, Rafferty E (2012) Is excisional biopsy required after a breast core biopsy yields lobular neoplasia? Am J Roentgenol 199(4):929–935

    Google Scholar 

  28. Purdie C, McLean D, Stormonth E, Macaskill EJ, McCullough J, Edwards SL, Brown DC, Jordan LB (2010) Management of in situ lobular neoplasia detected on needle core biopsy of breast. J Clin Pathol 63(11):987–993

    PubMed  Google Scholar 

  29. Atkins K, Cohen M, Nicholson B, Rao S (2013) Atypical lobular hyperplasia and lobular carcinoma in situ at core breast biopsy: use of careful radiologic-pathologic correlation to recommend excision or observation. Radiology 269(2):340–347

    PubMed  Google Scholar 

  30. Rendi M, Dintzis S, Lehman C, Calhoun K, Allison K (2011) Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy. Ann Surg Oncol 19(3):914–921

    PubMed  Google Scholar 

  31. Shah-Khan M, Geiger X, Reynolds C, Jakub J, DePeri E, Glazebrook K (2012) Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol 19(10):3131–3138

    PubMed  Google Scholar 

  32. Lewis J, Lee D, Tartter P (2012) The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast. Ann Surg Oncol 19(13):4124–4128

    PubMed  Google Scholar 

  33. Sohn VY, Arthurs ZM, Kim FS, Brown TA (2008) Lobular neoplasia: is surgical excision warranted? Am Surg 74(2):172–177

    PubMed  Google Scholar 

  34. Chaudhary S, Lawrence L, McGinty G, Kostroff K, Bhuiya T (2013) Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy. Mod Pathol 26(6):762–771

    PubMed  Google Scholar 

  35. Holbrook A, Hanley K, Jeffers C, Kang J, Cohen M (2019) Triaging atypical lobular hyperplasia and lobular carcinoma in situ on percutaneous core biopsy to surgery or observation: assiduous radiologic-pathologic correlation works, quantitating extent of disease does not. Arch Pathol Lab Med 143(5):621–627

    PubMed  Google Scholar 

  36. Rageth CJ, O’Flynn EA, Pinker K et al (2019) Second international consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 174(2):279–296

    PubMed  Google Scholar 

  37. Rageth CJ, O’Flynn EA, Comstock C et al (2016) First international consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 159(2):203–213

    PubMed  PubMed Central  Google Scholar 

  38. Calhoun BC, Collins LC (2016) Recommendations for excision following core needle biopsy of the breast: a contemporary evaluation of the literature. Histopathol 68(1):138–151

    Google Scholar 

  39. Lee J, Kaplan J, Murray M, Bartella L, Morris EA, Joo S, Dershaw DD, Liberman L (2007) Imaging–histologic discordance at MRI-guided 9-gauge vacuum-assisted breast biopsy. Am J Roentgenol 189(4):852–859

    Google Scholar 

  40. Liberman L, Drotman M, Morris E, LaTrenta L, Abramson AF, Zakowski MF, Dershaw DD (2000) Imaging-histologic discordance at percutaneous breast biopsy. Cancer 89(12):2538–2546

    CAS  PubMed  Google Scholar 

  41. Youk J, Kim E, Kwak J, Son E, Park B, Kim S (2011) Benign papilloma without atypia diagnosed at US-guided 14-gauge core-needle biopsy: clinical and US features predictive of upgrade to malignancy. Radiology 258(1):81–88

    PubMed  Google Scholar 

  42. Nakhlis F, Ahmadiyeh N, Lester S, Raza S, Lotfi P, Golshan M (2014) Papilloma on core biopsy: excision vs. observation. Ann Surg Oncol 22(5):1479–1482

    PubMed  Google Scholar 

  43. Bernstein J, Thompson W, Risch N, Holford T (1992) Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 136(8):925–936

    CAS  PubMed  Google Scholar 

  44. Hankey BF, Curtis RE, Darlene Naughton M, Boice JD, Flannery JT (1983) A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst 70(5):797–804

    CAS  PubMed  Google Scholar 

  45. Cook L, White E, Schwartz S, McKnight B, Daling J, Weiss N (1996) A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). Cancer Causes Control 7(3):382–390

    CAS  PubMed  Google Scholar 

  46. Pareja F, Corben A, Brennan S, Murray MP, Bowser ZL, Jakate K, Sebastiano C, Morrow M, Morris EA, Brogi E (2016) Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: rate of upgrade to carcinoma at excision. Cancer 122(18):2819–2827

    PubMed  PubMed Central  Google Scholar 

  47. Han S, Kim M, Chung Y et al (2018) Benign Intraductal papilloma without atypia on core needle biopsy has a low rate of upgrading to malignancy after excision. J Breast Cancer 21(1):80

    PubMed  PubMed Central  Google Scholar 

  48. Bahl M, Baker J, Kinsey E, Ghate S (2015) Architectural distortion on mammography: correlation with pathologic outcomes and predictors of malignancy. Am J Roentgenol 205(6):1339–1345

    Google Scholar 

  49. Baker J, Rosen E, Lo J, Gimenez E, Walsh R, Soo M (2003) Computer-aided detection (CAD) in screening mammography: sensitivity of commercial CAD systems for detecting architectural distortion. Am J Roentgenol 181(4):1083–1088

    Google Scholar 

  50. Johnston J, Clee C (1991) Analysis of 308 localisation breast biopsies in a New Zealand hospital. Australas Radiol 35(2):148–151

    CAS  PubMed  Google Scholar 

  51. Knutzen A, Gisvold J (1993) Likelihood of malignant disease for various categories of mammographically detected, nonpalpable breast lesions. Mayo Clin Proc 68(5):454–460

    CAS  PubMed  Google Scholar 

  52. Leung J, Sickles E (2007) Developing asymmetry identified on mammography: correlation with imaging outcome and pathologic findings. Am J Roentgenol 188(3):667–675

    Google Scholar 

  53. Sperber F, Metser U, Gat A, Shalmon A, Yaal-Hahoshen N (2007) Focal asymmetric breast density: mammographic, sonographic and pathological correlation in 97 lesions--a call to restrain biopsies. Isr Med Assoc J 9(10):720–723

    PubMed  Google Scholar 

  54. Shetty M, Watson A (2002) Sonographic evaluation of focal asymmetric density of the breast. Ultrasound Q 18(2):115–121

    PubMed  Google Scholar 

  55. Schnitt S, Collins L (2018) Biopsy interpretation of the breast. Wolters Kluwer, Philadelphia

    Google Scholar 

  56. Hassell P, Klein-Parker H, Worth A, Poon P (1999) Radial sclerosing lesions of the breast: mammographic and pathologic correlation. Can Assoc Radiol J 50(6):370–375

    CAS  PubMed  Google Scholar 

  57. Lopez-Medina A, Cintora E, Mugica B, Opere E, Vela A, Ibanez T (2006) Radial scars diagnosed at stereotactic core-needle biopsy: surgical biopsy findings. Eur Radiol 16(8):1803–1810

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

ISG conceived, designed, and analyzed the data and wrote the manuscript. SH designed, edited, and reviewed the manuscript and supervised the study. BT analyzed the data and edited and reviewed the manuscript. CQ collected some of the histologic slides and edited and reviewed the manuscript. LC edited and reviewed the manuscript. All the authors gave final approval for publication. ISG takes full responsibility for the work as a whole including the decision to submit and publish the manuscript.

Corresponding author

Correspondence to Iskender Sinan Genco.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Requirement for obtaining informed consent was waived by Northwell Health Institutional Review Board.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Quality in Pathology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Genco, I.S., Tugertimur, B., Chang, Q. et al. Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study. Virchows Arch 476, 209–217 (2020). https://doi.org/10.1007/s00428-019-02685-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-019-02685-8

Keywords

Navigation